Transfusion transmitted infections in solid organ transplantation

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 547-554

  Mezochow, A K ^a   Henry, R ^a   Blumberg, E A ^b   Kotton, C N ^c  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical research; complication: infectious; infection and infectious agents; infectious disease; practice; transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; ERYTHROCYTE TRANSFUSION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALARIA; ORGAN TRANSPLANTATION; PIROPLASMOSIS; PLASMA TRANSFUSION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; TRANSFUSION TRANSMITTED INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ADVERSE EFFECTS; CYTOMEGALOVIRUS INFECTIONS; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; TRANSMISSION; VIROLOGY; VIRUS DISEASES; WEST NILE FEVER; WEST NILE VIRUS;

BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRUS DISEASES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84921446575     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13006     Document Type: Article

References (41)

1. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495-1504.
2. Department of Health and Human Services. The 2011 national blood collection, utilization survey report. Washington, DC: DHHS, 2013.
3. Food and Drug Administration Center for Biologics Evaluation and Research. Fatalities Reported to FDA following blood collection and transfusion: Annual summary for fiscal year 2013. Rockville, MD: Food and Drug Administration, 2014.
4. Zou S, Stramer SL, Dodd RY., Donor testing and risk: Current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2012; 26: 119-128.
5. Stramer SL, Notari EP, Krysztof DE, Dodd RY., Hepatitis B virus testing by minipool nucleic acid testing: Does it improve blood safety ? Transfusion 2013; 53: 2449-2458.
6. Greenwald MA, Kuehnert MJ, Fishman JA., Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis 2012; 18: e1.
7. Organ Procurement and Transplantation Network. OPTN Policies. 2014. Available at: http://optn.transplant.hrsa.gov/ContentDocuments/OPTN-Policies.pdf. Accessed April 30, 2014.
8. CDC. West Nile virus transmission via organ transplantation and blood transfusion-Louisiana 2008. MMWR 2009; 58: 1263-1267.
9. CDC. HIV transmission through transfusion-Missouri and Colorado, 2008. MMWR 2010; 59: 1335-1339.
10. CDC. West Nile virus transmission through blood transfusion-South Dakota, 2006. MMWR 2007; 56: 76-79.
11. CDC. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion-Michigan, 2002. MMWR 2002; 51: 879.
12. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
13. Murtagh B, Wadia Y, Messner G, Allison P, Harati Y, Delgado R., West Nile virus infection after cardiac transplantation. J Heart Lung Transplant 2005; 24: 774-776.
14. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203.
15. Lux JZ, Weiss D, Linden JV, Kessler D, Herwaldt BL, Wong SJ, et al. Transfusion-associated babesiosis after heart transplant. Emerg Infect Dis 2003; 9: 116-119.
16. Talabiska DG, Komar MJ, Wytock DH, Rubin RA., Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol 1996; 91: 376-379.
17. Barat LM, Zucker JR, Barber AM, Parise ME, Paxton LA, Roberts JM, et al. Malaria surveillance-United States, 1993. MMWR CDC Surveill Summ 1997; 46: 27-47.
18. Perdrizet GA, Olson NH, Krause PJ, Banever GT, Spielman A, Cable RG., Babesiosis in a renal transplant recipient acquired through blood transfusion. Transplantation 2000; 70: 205-208.
19. Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry: Use of nucleic acid tests to reduce the risk of transmission of West Nile virus from donors of whole blood and blood components intended for transfusion. Rockville, MD: Food and Drug Administration, 2009.
20. Mañez R, Kusne S, Martin M, et al. The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993; 33: 594-597.
21. Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG., Primary cytomegalovirus infection in liver transplant recipients: Comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 1996; 23: 292-297.
22. Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: A prospective multivariate time-dependent analysis. J Hepatol 1993; 18: 185-195.
23. Stratta RJ, Shaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC, et al. Cytomegalovirus infection and disease after liver transplantation: An overview. Dig Dis Sci 1992; 37: 673-688.
24. Stratta RJ, Shaefer MS, Markin RS, Wood RP, Kennedy EM, Langnas AN, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 1443-1450.
25. Gorensek MJ, Stewart RW, Keys TF, McHenry MC, Goormastic M., A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. J Infect Dis 1988; 157: 515-522.
26. Chou S, Kim DY, Norman DJ., Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates. J Infect Dis 1987; 155: 565-567.
27. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988; 158: 124-131.
28. Rubin RH, Tolkoff-Rubin NE, Oliver D, et al. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243-249.
29. Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT., Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152: 1182-1191.
30. Preiksaitis JK, Rosno S, Grumet C, Merigan TC., Infections due to herpesviruses in cardiac transplant recipients: Role of the donor heart and immunosuppressive therapy. J Infect Dis 1983; 147: 974-981.
31. Gorensek MJ, Carey WD, Vogt D, Goormastic M., A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology 1990; 98: 1326-1332.
32. Bate SL, Dollard SC, Cannon MJ., Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010; 50: 1439-1447.
33. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD., Use of leukocyte depleted platelets and cytomegalovirus seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991; 78: 246-250.
34. Altman LK., Officials warn that transfusions carry the risk of West Nile virus. The New York Times 2002 Sept 20. Available at: http://www.nytimes.com/2002/09/20/us/officials-warn-that-transfusions-carry-the-risk-of-west-nile-virus.html. Accessed July 20, 2014.
35. New Test Finds West Nile in Donated Blood. The New York Times 2003 July 4. Available at: http://www.nytimes.com/2003/07/04/us/new-test-finds-west-nile-in-donated-blood.html. Accessed July 20, 2014.
36. Altman LK, Testing Finds, Blood Donors, Are Carrying, Nile Virus., The New York Times. 2003 Sept 19. Available at: http://www.nytimes.com/2003/09/19/us/testing-finds-blood-donors-are-carrying-nile-virus.html. Accessed July 20, 2014.
37. Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry: Biological product deviation reporting for blood and plasma establishments. Rockville, MD: Food and Drug Administration, 2006.
38. Glynn S, Establishing A., U.S. donor transfusion-transmissible infection monitoring system-next steps. Presented at the Advisory Committee on Blood and Tissue Safety and Availability. Rockville, MD, December 5, 2013.
39. AABB. Full-length donor history questionnaire. 2008; Available at: https://www.aabb.org/resources/donation/questionnaires/Documents/dhq/v1-3/Full-LengthDonorHistoryQuestionnairev1.3.pdf. Accessed April 30, 2014.
40. American Association of Tissue Banks. Donor risk assessment interview (donor >12 yrs old). 2012. Available at: http://www.aatb.org/Donor-Risk-Assessment-Interview-DRAI. Accessed April 30, 2014.
41. Vassallo R, Bachowski G, Benjamin RJ, et al. A compendium of transfusion practice guidelines, 2nd ed. Washington, DC: American Red Cross, 2013.